11-57610852-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000062.3(SERPING1):​c.1030-865C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 152,014 control chromosomes in the GnomAD database, including 11,774 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.39 ( 11774 hom., cov: 32)

Consequence

SERPING1
NM_000062.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.452

Publications

47 publications found
Variant links:
Genes affected
SERPING1 (HGNC:1228): (serpin family G member 1) This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020]
SERPING1 Gene-Disease associations (from GenCC):
  • hereditary angioedema with C1Inh deficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • C1 inhibitor deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary angioedema type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary angioedema type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 11-57610852-C-T is Benign according to our data. Variant chr11-57610852-C-T is described in ClinVar as Benign. ClinVar VariationId is 983234.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000062.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPING1
NM_000062.3
MANE Select
c.1030-865C>T
intron
N/ANP_000053.2
SERPING1
NM_001032295.2
c.1030-865C>T
intron
N/ANP_001027466.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SERPING1
ENST00000278407.9
TSL:1 MANE Select
c.1030-865C>T
intron
N/AENSP00000278407.4
SERPING1
ENST00000619430.2
TSL:1
c.826-865C>T
intron
N/AENSP00000478572.2
SERPING1
ENST00000531133.5
TSL:1
n.*399-865C>T
intron
N/AENSP00000435431.1

Frequencies

GnomAD3 genomes
AF:
0.388
AC:
58952
AN:
151896
Hom.:
11762
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.420
Gnomad AMI
AF:
0.218
Gnomad AMR
AF:
0.343
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.133
Gnomad SAS
AF:
0.362
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.414
Gnomad OTH
AF:
0.375
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.388
AC:
59005
AN:
152014
Hom.:
11774
Cov.:
32
AF XY:
0.382
AC XY:
28374
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.420
AC:
17411
AN:
41446
American (AMR)
AF:
0.343
AC:
5242
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
884
AN:
3472
East Asian (EAS)
AF:
0.133
AC:
690
AN:
5172
South Asian (SAS)
AF:
0.362
AC:
1748
AN:
4824
European-Finnish (FIN)
AF:
0.364
AC:
3840
AN:
10554
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.414
AC:
28113
AN:
67956
Other (OTH)
AF:
0.374
AC:
790
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1885
3769
5654
7538
9423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
562
1124
1686
2248
2810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.398
Hom.:
25932
Bravo
AF:
0.385
Asia WGS
AF:
0.260
AC:
908
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary angioedema type 1 Benign:1
CeMIA
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (BA1), allele frequency is greater than expected for disorder (BS1), it is observed in a healthy adult individual (BS2), it is predicted to be benign by multiple in silico algorithms (BP4), it is found in a case with an alternate molecular basis for the disease (BP5) and/or reputable source recently reports variant as benign (BP6).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.60
DANN
Benign
0.64
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2511989; hg19: chr11-57378325; API